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ABSTRACT
Objectives: The purpose of this systematic literature
review is to examine the current state of knowledge
regarding the return-to-work outcomes of sickness
absences related to mental disorders that increase costs
borne by employers. We address two questions: (1)
Based on the existing literature, from the employer’s
perspective, what are the relevant economic return-to-
work outcomes for sickness absences related to mental
disorders? and (2) From the employer’s economic
perspective, are there gaps in knowledge about the
relevant return-to-work outcomes for sickness absences
related to mental disorders?
Setting: The included studies used administrative data
from either an employer, insurer or occupational
healthcare provider.
Participants: Studies included working adults between
18 and 65 years old who had a sickness absence related
to a mental disorder.
Primary and secondary outcome measures: The
studies considered two general return-to-work outcome
categories: (1) outcomes focusing on return-to-work
and (2) outcomes focusing on sickness absence
recurrence.
Results: A total of 3820 unique citations were
identified. Of these, 10 studies were identified whose
quality ranged from good to excellent. Half of the
identified studies came from one country. The studies
considered two characteristics of sickness absence: (1)
whether and how long it took for a worker to return-to-
work and (2) sickness absence recurrence. None of the
studies examined return-to-work outcomes related to
work reintegration.
Conclusions: The existing literature suggests that
along with the incidence of sickness absence related to
mental disorders, the length of sickness absence
episodes and sickness absence recurrence (ie, number
and time between) should be areas of concern.
However, there also seems to be gaps in the literature
regarding the work reintegration process and its
associated costs.
Around the world, there is increasing
awareness about the economic costs of
mental disorders. Estimates suggest that a
large share of the burden of mental disor-
ders can be attributed to work productivity
losses. Between 30% and 60% of depression’s
cost is related to losses associated with
decreased work productivity.1 2 Decreased
work productivity has been measured as
work absences or an unproductive work day.
Owing to the fact that they take a societal
perspective, most of the economic burden
estimates for mental disorders rely on survey
data (eg, 1 3 4). One of the most identifiable
types of work absences is related to sickness
Strengths and limitations of this study
▪ Few studies have examined the current state of
knowledge about sickness absence outcomes
from the employer perspective; this paper exam-
ines the current state of knowledge regarding the
return-to-work outcomes of sickness absences
related to mental disorders that increase workplace
burdens from the perspective of the employer.
▪ This systematic literature review employed a broad
search of five electronic databases: (1) Medline
Current, (2) Medline In-process, (3) PsycINFO, (4)
Econlit and (5) Web of Science. A manual search
was also conducted. In total, 3820 unique citations
were identified and reviewed by two reviewers.
▪ All included studies were based on data from
complete populations of people who had a sick-
ness absence; this minimises the potential for
selection bias within populations.
▪ The results of this review suggest that along with
the incidence of sickness absence related to mental
disorders, the length and sickness absence recur-
rence (ie, frequency of sickness absence recurrence
and time between sickness absence episodes) of
these sickness absences should be areas of
concern and future research. This highlights the
importance of evaluating interventions with respect
to these two aspects of sickness absences rather
than focusing solely on whether or not a worker
returns to work.
▪ The results of the search identified 10 papers
that met inclusion criteria; this suggests that we
are in the early stages of understanding the
aspects of sickness absences that contribute to
their burden and the areas to target to effectively
decrease their costs.
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absences. Yet, few estimates specifically have taken sick-
ness absences into account. Sickness absences are
defined as work absences that require a medical certifi-
cation and have an associated income replacement
benefit. The costs of these specific types of absences are
not only borne by society but employers in particular.
Furthermore, because they involve the workplace,
employers often assume the costs and responsibilities for
implementing the interventions to address sickness
absences. Thus, to effectively build the business case for
employers to invest in interventions that target sickness
absences related to mental disorders, it is important to
identify the costs that employers recognise and directly
bear. By using a comprehensive estimate of costs in eco-
nomic evaluations and economic models we could more
accurately estimate the types of cost savings that employ-
ers can expect with an intervention.
The concern among employers regarding mental dis-
orders has been fuelled by the recognition that sickness
absence episodes related to a mental disorder are costly
and their incidence is steadily rising.5 Estimates suggest
that an episode related to a mental disorder can be
double the cost of one related to a physical disorder.6
The calculation of the cost of sickness absences related
to mental disorders is comprised of two types of factors:
(1) the number of days absent and (2) the total number
of sickness absences. It can be expected that the more
sickness absence days, the greater the total cost of the
sickness absence. In addition, high costs could be
incurred with short sickness episodes if there are many
repeat sickness episodes.
One approach to addressing the costs of sickness
absence related to mental disorders could be to
decrease the impact of the number of episodes and
their lengths. This suggests that interest should extend
beyond merely whether or not a worker returns-to-work.
Rather, it is also important to understand the length and
the frequency of sickness absence related to mental dis-
orders. Few studies have examined the current state of
knowledge about sickness absence outcomes from the
employer perspective. To fill this gap, we conducted a
systematic literature review to examine the sickness
absence outcomes reported in the literature. These out-
comes could help to identify the aspects of sickness
absences that contribute to employer economic
burdens.
PURPOSE OF THE PAPER
The purpose of this paper is to examine the current
state of knowledge regarding the return-to-work (RTW)
outcomes of sickness absences related to mental disor-
ders that increase workplace burdens from the perspec-
tive of the employer. The question that we addressed in
this systematic review was, ‘Based on the existing litera-
ture, from the employer’s perspective, what are the rele-
vant economic return-to-work outcomes for sickness
absences related to mental disorders?’ Answers to this
question can highlight the aspects of sickness absences
related to mental disorders that could escalate the costs
that employers face. Results of this review can point to
areas that sickness absence interventions could target.
They can also suggest dimensions along which future
intervention effectiveness could be evaluated.
A secondary question we asked was, ‘From the employ-
er’s economic perspective, are there gaps in knowledge
about the relevant return-to-work outcomes for sickness
absences related to mental disorders?’ In answering this
question, this review takes a first step in understanding
where the knowledge in this area is and is not being pro-
duced. It also suggests areas where additional study is
needed to more accurately estimate the costs of sickness
absences borne by employers.
METHODS
This systematic literature review used publically available
peer-reviewed studies. It neither involved the collection
of nor the use of primary data. As such, it was not
subject to research ethics board review.
Five electronic databases were searched for this system-
atic literature review: (1) Medline Current (an index of
biomedical research and clinical sciences journal arti-
cles), (2) Medline In-process (an index of biomedical
research and clinical sciences journal articles awaiting
indexing into Medline Current), (3) PsycINFO (an index
of journal articles, books, chapters and dissertations in
psychology, social sciences, behavioural sciences and
health sciences), (4) Econlit (an index of journal articles,
books, working papers and dissertations in Economics)
and (5) Web of Science (an index of journal articles, edi-
torially selected books and conference proceedings in
life sciences and biomedical research). A search strategy
was developed and executed for each database with a
professional health science librarian (SB) (see online
supplementary File 1—Search Strategy). Medline Current,
Medline In-process and PsychINFO were searched using the
OVID platform. Econlit and Web of Science were searched
using the ProQuest and Thomson Reuters search interface,
respectively. The search was completed between
February 2013 and March 2013 and was limited to
English language journals published between 2002 and
2013.
Eligibility criteria
The systematic literature search focused on the RTW
outcomes of sickness absences of workers with medically
certified sickness absences related to mental disorders.
Sickness absence encompassed sick leave, short-term dis-
ability leave and long-term disability leave. These sick-
ness absence benefits could be either publicly or
privately sponsored. Their receipt was conditional on
employment and the absence benefit was claimed with
the intention of continued employment. We included
studies that looked at ‘no cause’ sickness absences such
that it was not compulsory that the absence was work-
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related. The search focused on identifying articles about
working adults between 18 and 65 years old who had a
sickness absence related to a mental disorder. Sickness
absence outcome terms (ie, length of sickness absence,
RTW, etc) were not included in the search strategy. This
was performed to ensure all reported sickness absence
outcomes in the literature would be captured. The refer-
ence lists of relevant studies were manually searched.
Intervention studies, review articles and commentaries
were excluded.
A multiphase screening process was employed. The
first phase involved screening titles. Citations that passed
the first phase were evaluated for relevance based on
their abstracts. Finally, those that passed the abstract
screen were evaluated for content based on the full-text.
The multiphase screening process was completed inde-
pendently by two reviewers, CSD and DL. The chance
agreement corrected inter-rater reliability was 0.92.
Articles for which there were rater disagreements were
discussed until consensus was reached.
The following eligibility criteria were used in each
phase:
1. The study reported on medically certified sickness
absences due to mental disorders.
2. The study sample is not from a select (ie, clinical
trial) population.
3. The study analysed data that were collected in the
year 2000 or later.
4. The study reported on sickness absence outcomes
directly related to a specific absence.
Sickness absence outcomes considered for this review
included length of sickness absence, not returning to
work (ie, quitting, retiring), transitioning to long-term
disability, RTW and sickness absence recurrence.
Owing to the fact that the 1990s was a period of global
change in disability policies and accounting for publica-
tion lag, the year 2002 was used as an inclusion starting
point.7 We focused on the last decade because there were
relatively fewer policy changes related to workers during
this time. Studies using pre-2000 data were excluded
because pre-2000 data were collected within systems that
existed before many of the 1990s policy changes.
Quality assessment
Articles that passed the three-stage screening process
were then assessed for quality using the following
criteria:
1. The study population is well described.
2. The data source is well described.
3. The study sample is representative of all workers in
the context.
4. Mental disorders are included and reported.
5. The system of diagnosis/classification is described.
6. The sickness absence criteria are reported (ie, pre-
sickness absence days to qualify for sickness
absence).
7. Sickness absence outcome measures are defined.
8. Analytical methods are described.
9. Uncertainty of estimates are reported.
10. The stated research objective is met.
One point was awarded for each criterion that was
met; the maximum score was 10. Total scores between 1
and 4 points were categorised as fair/weak quality, those
between 5 and 8 points were good and those between 9
and 10 points were excellent quality.
RESULTS
Description of inclusion and exclusion
The electronic literature search resulted in the identifi-
cation of 3820 unique citations (figure 1). From these,
24 entries that were commentaries were excluded. Based
on the title review, 3577 citations were excluded. During
the abstract review, another 151 citations were excluded;
this left 64 articles for full-text review. After the full-text
review, 10 articles remained and their reference lists
were manually searched for relevant studies. Four arti-
cles were identified in the manual search process but all
were excluded during full-text review. Reasons for article
exclusions were because they: (1) used pre-2000 data
(n=11), (2) did not report sickness absence outcomes
directly related to a specific absence (n=3), (3) were
based on select populations (n=44).
Quality assessment
On quality assessment, 5 of the 10 studies were rated as
excellent and the remaining 5 as good (see online supple-
mentary File 2—Quality assessment). The identified lim-
itations of these studies included: non-representativeness
of the working population (n=10), outcome measure
not defined (n=4), and uncertainty of the estimate not
reported (n=3).
Overview of the studies
Table 1 contains the descriptions of the included studies.
All of the included studies used administrative data from
either an employer, insurer or occupational healthcare
provider. As a result, none of the studies relied on self-
report. They were based on objective data to identify popu-
lations of people with a sickness absence.
Of the 10 included studies, five were from the
Netherlands. Two were from Brazil, two were from Canada
and another from the UK. Seven of the studies used data
from single employers. The employers in the studies repre-
sented a variety of sectors in several countries including a
Dutch national postal service and a telecommunication
company,8–10 a Brazilian hospital,11 a Canadian resource
sector organisation6 12 and a British police force.13 The
four exceptions were Barbosa-Branco et al14 whose study
included all Brazilian workers in registered private sector
companies. In addition, Koopman et al15 and
Roelen et al16 based their studies on data from an occupa-
tional health provider representing a broad spectrum of
firms across the Netherlands.
All of the studies except one indicated that they used
the International Classification of Diseases (ICD) to
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identify type of disorder. Of those that used the ICD,
eight of the studies were based on the 10th edition and
one on the 8th edition. One study15 did not describe
the disorder classification system it employed. However,
because it used ArboNed data that were also used by
Roelen et al,16 it might be assumed that ICD codes were
also used in this study.
Among the studies, there was variability in the scope
of the primary diagnoses associated with the sickness
absences that were included. However, there were simi-
larities with respect to the inclusion of depressive and
anxiety disorders and stress-related disorders. Thus,
there appeared to be consistency among the studies with
regard to a core set of mental disorders.
Figure 1 Flowchart of literature
search results and inclusions/
exclusions.
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Table 1 Overview of studies
Author(s) Country Study population Data source(s)
Years of
data
Diagnostic
classification
system used
Sickness absence
benefit definition Outcomes
Barbosa-Branco et al14 BR All employees in registered
private sector jobs in 2008 who
had a sickness absence
Brazilian National
Social Security
Administrative
Databases: National
Benefits System and
National Social
Information Database
2008 International
Classification of
Diseases,10th
edition (ICD-10)
Sickness absence
=≥15 medically
certified consecutive
days absent
Duration of sickness
benefit claim
(calendar vs work
days not specified)
Board and Brown13 UK Study sample consisted of all
employees of one police force
who had ≥1 episode of
long-term sickness absence
(LTSA) between Nov 1, 2000
and Oct 31, 2002
Employer electronic
absenteeism record
administrative data
2000–2002 International
Classification of
Diseases,8th
edition (ICD-8)
Long-term sickness
absence =medically
certified sickness
absence episodes
≥28 consecutive
calendar days
Return to work by
type of sickness
absence episode
(subacute or chronic)
Dewa et al6 CA Employees from one large
resource sector company from
2003–2006 who had a sickness
absence
Employer
administrative sickness
absence data
2003–2006 ICD-10 Sickness absence =
medically certified
sickness absence of
≥5 continuous work
days
Mean work days per
sickness absence
episode
Dewa et al12 CA Employees from one large
resource sector company from
2003–2006 who had a sickness
absence
Employer
administrative sickness
absence data
2003–2006 ICD-10 Sickness absence =
medically certified
sickness absence of
≥5 continuous work
days
Sickness absence
free days
Koopmans et al15 NL Employees of firms who were
clients of one occupational
health services provider from
April 2002—November 2005
who had a sickness absence
Administrative sickness
absence data from one
occupational health
service provider
(ArboNed)
2002–2005 Not described Not described Return to work
Duration of absence
calendar days
Koopmans et al9 NL Dutch Post and
Telecommunication employees
from 2001–2007 who had a
sickness absence due to a
common mental disorder since
Jan 1 2001 or date of
employment
Administrative sickness
absence data from one
occupational health
service provider
(ArboNed)
2001–2007 ICD-10 Sick leaves of
>3 weeks require a
medical certificate
from an
occupational
physician
Duration of sickness
absence days
(calendar vs work
days not specified)
Days to sickness
absence recurrence
Koopmans et al8 NL Dutch Post and
Telecommunication employees
from 2001–2007 who had a
sickness absence due to a
common mental disorder
Administrative sickness
absence data from one
occupational health
service provider
(ArboNed)
2001–2007 ICD-10 Sick leaves of
>3 weeks require a
medical certificate
from an
occupational
Duration of sickness
episodes
Median duration in
months until
recurrence of sickness
Continued
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Table 1 Continued
Author(s) Country Study population Data source(s)
Years of
data
Diagnostic
classification
system used
Sickness absence
benefit definition Outcomes
physician absence
Days to sickness
absence recurrence
Recurrence = the start
of at least one new
episode of sickness
absence after
complete return to
work for ≥28 days
Reis et al11 BR Workers who worked ≥20 h/
week from one university
hospital who were employed
from 2000–2007 who had at
least 1 sickness absence
Administrative data
from employer human
resources department
2000–2007 ICD-10 Not described Median calendar days
per sickness absence
Recurrence density of
sickness absence
episodes/100
worker-months
Roelen et al16 NL Employees of firms who were
clients of an occupational
health services provider from
2001–2007 who had a sickness
absence
Administrative sickness
absence data from one
occupational health
service provider
(ArboNed)
2001–2007 ICD-10 Sickness absence:
absence of ≥28 sick
days requiring a
medical certificate
from an
occupational
physician
Median number of
calendar days of
sickness absence
episodes/100
employees
Roelen et al10 NL Dutch Post and
Telecommunication employees
from 2001–2007 who had a
sickness absence
Administrative sickness
absence data from one
occupational health
service provider
(ArboNed)
2001–2007 ICD-10 Sick leaves of
>3 weeks require a
medical certificate
from an
occupational
physician
Median duration of
sickness absence in
days (type of day not
specified)
Recurrence density of
sickness absence/
1000 worker-years
Days to recurrence
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There was variation with regard to the number of
absence days needed to qualify for sickness absence ben-
efits. The number of days ranged from 1 to 3 weeks.
Sickness absence outcomes
The outcomes reported by the studies could be grouped
into two general categories. The first outcome category
includes studies that examined whether and when a
worker returned to work. They included RTW indicators
and sickness absence duration. The second category of
outcomes focused on sickness absence recurrence.
These recurrence outcomes reflected the rates of sick-
ness absence recurrence as well as the time between sick-
ness absence episodes.
Outcomes focusing on RTW
Three studies reported the rates of RTW (table 2).
Koopmans et al15 observed that of workers who had sick-
ness absences due to depression, 66% returned to work
within a year. Board and Brown13 found that among
their police force, 85% of police officers who had a sick-
ness absence returned to work.
Duration of sickness absence
Duration of sickness absence was measured using three
types of days—calendar days, work days and unspecified
types of days. Sickness absence days were reported using
two statistics—the mean days and the median days. The
values of the mean and the median become equivalent
when a distribution is symmetric (eg, the normal
distribution). From the Netherland studies, the median
days of absence duration were between 79 and
119 days.8–10 15 16 In addition, there were changes in the
median number of days over time such that they seemed
to decrease between 2001 and 2007.16 From Brazil, Reis
et al11 reported a duration of 5–7 calendar days. Using
Canadian data, Dewa et al6 reported a mean absence
episode of 65 work days. From the UK, Board and
Brown13 found that 43–60% of the workers they
observed had a sickness absence episode that was
between 28–90 days; about 41–57% had sickness absence
episodes that lasted more than 90 days.
Four of the studies compared sickness absence
episode duration for those related to mental disorders
versus those for other disorders. The findings among
the four studies were consistent; episodes for mental dis-
orders were longer than episodes related to other types
of disorders. For instance, Roelen et al10 reported that
while the median duration of a mental disorder related
episode was 62 days, it was 35 days for any type of
episode. In addition, this pattern appeared to be consist-
ent from 2001 to 2007.16 Among their Canadian energy
sector workers, Dewa et al6 found that the mean number
of work days of an episode related to a mental disorder
was almost double that of an episode related to other
types of disorders (65 days vs 33 days). Reis et al11
reported similar patterns among their sample of
Brazilian healthcare workers.
Outcomes focusing on sickness absence recurrence
Three of the studies reported rates of sickness absence
recurrence related to a mental disorder (table 3). Roelen
et al10 reported recurrence rates of 80/1000 worker-years
for mental and behavioural disorders as opposed to
82/1000 worker-years for any disorder. Reis et al11 found
rates of 7/100 worker-months for mental and behavioural
disorders and 17/100 worker-months for any disorder. In
addition, Koopmans et al9 observed mental disorder sick-
ness absence recurrence rates of 76/1000 worker-years
for men and 79/1000 worker-years for women. They also
found that 18% of workers with at least one sickness
absence episode had a recurrent episode.9
Time between sickness absence episodes
Four studies reported the time between episodes related
to mental disorders. Koopmans et al8 found that the
median time was 10 months. In addition, Koopmans
et al9 observed the median lengths of episode free-
months were similar for men (11 months) and women
(10 months).
Roelen et al10 compared lengths of episode free-days
for those related to mental disorders versus those related
to any disorder. They found the median length of
episode free days was longer for workers who had a previ-
ous sickness absence episode for any disorder (384 days)
versus those who had a previous episode related to a
mental disorder (328 days). Dewa et al12 also observed a
longer period of sickness absence free days for workers
who had a previous sickness absence episode related to a
physical disorder (1053 days) than those who had a previ-
ous sickness absence episode related to a mental disorder
(673 days).
DISCUSSION
Based on the existing literature, from the employer’s
perspective, what are the relevant economic RTW out-
comes for sickness absences related to mental disorders?
The results of the 10 studies could be grouped into two
general outcome categories: (1) outcomes focusing on
RTW and (2) outcomes focusing on sickness absence
recurrence.
Two of the included studies that looked at RTW out-
comes indicated that the majority of workers who have a
sickness absence RTW at the end of the absence.13 15 This
trend is consistent with early studies that indicated a large
proportion of workers RTW at the end of their
absence.17 18 This suggests that retention of workers may
not be one of the major burdens associated with sickness
absence. It also raises the question of what happens to
workers who do not RTW at the end of their sickness
absence. This is particularly salient for North American (ie,
USA and Canada) employers who offer long-term work dis-
ability benefits to their workforces. Although a small
group, workers who receive long-term disability benefits
after reaching the limits of their sickness absence benefits
Dewa CS, et al. BMJ Open 2014;4:e005533. doi:10.1136/bmjopen-2014-005533 7
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Table 2 Return-to-work sickness absence outcomes
Author(s) Country Mental disorders Outcome measure
Number of episodes or
employees Reported outcomes of sickness absences
Barbosa-Branco et al14 BR Mental and behavioural
disorders: Organic
disorders (ICD-10
F00-F09);
psychoaffective
substance use
disorders (ICD-10
F10-F19);
schizophrenia,
schizotypal and
delusional disorders
(ICD-10 F20-F29);
mood disorders (ICD-10
F30-F39); stress-related
and somatoform
disorders (ICD-10
F40-F48)
Duration of sickness benefit
claim =measure not described
Number of claims due to
mental and behavioural
disorders:
All=147 105
Males=71 195
Females=75 910
Median duration of disability episodes
(in days) (1st and 3rd quartiles):
Males:
Mental and behavioural disorders=76
(47, 113)
Females:
Mental and behavioural disorders=65
(43, 97)
Board and Brown13 UK ICD categories used
not described
Absence phase:
Subacute=28–90 days
Chronic phase=>90 days
Return-to-Work=episode has
start and finish dates before
study end date
Number of sickness
absences:
Police officers=4485
Civilian staff=1761
Among those with mental ill health:
Police officers:
With subacute episode=43.2%
With chronic episode=56.8%
Who return to work=85.2%
Civilian staff:
With subacute episode=59.5%
With chronic episode=40.5%
Who return to work=Not reported
Dewa et al6 CA
(Ontario)
Mental and behavioural
disorders (ICD-10 F00-
F99, Z502, Z503, Z561-
Z566, Z630-Z639,
Z729, Z733, Z738,
Z864, Z915):
schizophrenia, mood
disorders, stress-related
disorders and mental
and behavioural
disorders due to
psychoactive substance
use
Duration of episode=number
of work days absent
Number of sickness
absences:
Due to any disorder=4791
Due to mental and
behavioural disorders=698
Mean days per episode (in days) (95%CI):
Due to any disorder=33.0 (31.3 to 34.7)
Due to mental and behavioural disorders:
All=64.9 (58.2 to 71.6)
Males=62.1 (54.1 to 70.1)
Females=70.0 (57.8 to 82.1)
Koopmans et al15 NL Depression (diagnostic
classification system not
descripted in paper)
Duration of episode=number
of calendar days between first
day of sick leave and date of
Number of new episodes
due to depression=9910
Return to work within a year:
Men=67.7%
Women=64.8%
Continued
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Table 2 Continued
Author(s) Country Mental disorders Outcome measure
Number of episodes or
employees Reported outcomes of sickness absences
return to work or disability
pension received
Total=66.2%
One year of work incapacity:
Men=15.2%
Women=17.4%
Total=16.4%
Mean duration of episode (in days) (95% CI):
Men=200 (196 to 204)
Women=213 (210, 217)
Median duration of episode (in days) (95% CI):
Men=179 (172 to 186)
Women=201 (193 to 209)
Koopmans et al 9 NL Common mental
disorders (CMD) from
medical certification:
stress-related (distress
and adjustment
disorders) (ICD-10 R45,
F43) and psychiatric
(mild to moderate
depressive and anxiety
disorders) (ICD-10
F32.0, F32.1, F40.0,
F40.1, F40.2, F41.0,
F41.1, F41.2, F41.3)
Duration of sickness
absence=number of calendar
days between first day of sick
leave and date of return to
work or disability pension
received
Number of employees with
≥1 sickness absence due
to CMD=8951
Total number of sickness
absence due to CMD=10
921
From 2001 to 2007, median duration of index
sickness absence episode (in days) (95% CI):
Men:
Stress=49 (47 to 51)
Psychiatric=168 (150 to 186)
Total CMD=57 (54 to 60)
Women:
Stress=56 (53 to 59)
Psychiatric=168 (151 to 185)
Total CMD=67 (63 to 71)
From 2001–2007, median duration of recurrent
CMD sickness absence episodes (in days)
(95% CI):
Men:
Stress=46 (41 to 51)
Psychiatric=68 (39 to 97)
Total CMD=48 (43 to 53)
Women:
Stress=60 (51 to 69)
Psychiatric=73 (53 to 93)
Total CMD=62 (55 to 69)
Koopmans et al 8 NL Common mental
disorders (CMD) from
medical certification:
stress-related (distress
and adjustment
disorders) (ICD-10 R45,
F43) and psychiatric
(mild to moderate
Duration of sickness
absence=number of calendar
days of sickness absence
adjusted for partial return to
work and annual worker-years
Number of employees with
≥1 sickness absence due
to CMD=9904
Total number of sickness
absences due to CMD=12
404
From 2001 to 2007, duration of sickness
absence episode due to CMD (in calendar
days) (95% CI):
Total=62 (60 to 64)
Men=57 (55 to 59)
Women=68 (65 to 71)
Continued
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Table 2 Continued
Author(s) Country Mental disorders Outcome measure
Number of episodes or
employees Reported outcomes of sickness absences
depressive and anxiety
disorders) (ICD-10 F32,
F40, F41)
Reis et al11 BR Mental and behavioural
disorders (ICD-10 F00-
F99)
Duration of episode=Number
of calendar days absent from
work
Number of sickness
absence episodes:
Due to any disorder=5138
Due to mental and
behavioural disorders=324
Median duration of sickness absence leave
(in days):
First episode:
Due to any disorder=2
Due to mental and behavioural disorders=5
Recurrent episodes:
Due to any disorder=2
Due to mental and behavioural disorders=7
Roelen et al16 NL Mental and behavioural
disorders (ICD-10 R45,
F43, F32, F40 and F41)
from medical
certification: emotional
disturbance, depressive
disorders, anxiety
disorders and stress-
related disorders
Duration of sickness
absence=calendar days
between the first and last day
of sickness absence
Number of sickness
absence episodes:
Due to any disorder:
2001=90 095
2002=104 193
2003=118 926
2004=129 024
2005=128 044
2006=108 901
2007=96 482
Due to mental and
behavioural disorders:
2001=21 140
2002=22 803
2003=24 917
2004=27 533
2005=22 682
2006=20 013
2007=18 513
Median duration of sickness absence
episodes (in days) (95% CI):
Due to any disorder:
2001=73 (72 to 74)
2002=63 (62 to 64)
2003=57 (56 to 58)
2004=53 (53 to 53)
2005=45 (45 to 45)
2006=49 (48 to 50)
2007=55 (54 to 56)
Due to mental and behavioural disorders:
2001=119 (116 to 122)
2002=98 (96 to 100)
2003=87 (85 to 89)
2004=80 (79 to 81)
2005=79 (77 to 81)
2006=83 (81 to 85)
2007=87 (85 to 89)
Roelen et al10 NL Mental and behavioural
disorders (ICD-10 F00-
F99) from medical
certification
Duration of sickness
absence=number of days
between first day of sick leave
and date of return to work or
disability pension received
Number of employees with
≥1 sickness absence=36
342
Number of employees with
≥1 sickness absence due
to mental and behavioural
disorders=7197
Number of employees with
>1 sickness absence due
to mental and behavioural
disorders=1400
Worker-years=363 461
Median duration of sickness absence (in
days) (95% CI):
Mental and behavioural disorders=62 (55 to
69)
Any disorder=35 (34 to 36)
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Table 3 Recurrence sickness absence outcomes
Author(s) Country Mental disorders Outcome measure
Number of episodes or
employees
Reported outcomes of sickness
absences
Dewa et al 12 CA
(Ontario)
Mental and behavioural
disorders (ICD-10 F00-F99,
Z502, Z503, Z561-Z566,
Z630-Z639, Z729, Z733, Z738,
Z864, Z915): schizophrenia,
mood disorders, stress-related
disorders and mental and
behavioural disorders due to
psychoactive substance use
Disability free days=number of
between end of first episode and
beginning of subsequent episode
Number of employees with
≥1 sickness absence
episode:
Due to mental disorders=422
Due to physical disorders=
3171
Median disability free days (SE):
Previous episode for mental
disorders=673 (79.8)
Previous episode for physical
disorders=1053 (48.6)
Koopmans et al 9 NL Common mental disorders
(CMD) from medical
certification: stress-related
(distress and adjustment
disorders) (ICD-10 R45, F43)
and psychiatric (mild to
moderate depressive and
anxiety disorders) (ICD-10
F32.0, F32.1, F40.0, F40.1,
F40.2, F41.0, F41.1, F41.2,
F41.3)
Recurrence density=number of
employees with recurrent episodes
by the worker-years in the
subpopulation of men and women
with a previous episode of sickness
absence due to a CMD
New episodes=>28 days apart
Worker-years=years of coverage
from index episode to end of
employment period
Number of employees with
≥1 sickness absence due to
CMD=8951
Total number of sickness
absence due to CMD=10 921
From 2001 to 2007, episodes per
worker with ≥ 1 sickness absence
related to CMD:
1 episode = 82%
2 episodes= 14%
3 episodes= 3%
≥ 4 episodes = 1%
From 2001 to 2007, CMD
recurrence densities/1000
worker-years (95% CI):
Men:
Stress=74.4 (72.9 to 76.0)
Psychiatric=83.8 (71.9 to 95.7)
Total CMD=75.6 (70.7 to 80.4)
Women:
Stress=78.4 (75.9 to 80.9)
Psychiatric=78.9 (64.1 to 93.7)
Total CMD=78.5 (72.4 to 84.6)
From 2001 to 2007, CMD sickness
absence median time to onset
recurrence (in months) (95% CI):
Men:
Stress=11 (11 to 13)
Psychiatric=12 (8 to 15)
Total CMD=11 (10 to 13)
Women:
Stress=11 (9 to 12)
Psychiatric=10 (8 to 12)
Total CMD=10 (9 to 12)
Koopmans et al 8 NL Common mental disorders
(CMD) from medical
certification: stress-related
Recurrence density=number of
employees with recurrent episodes
by the worker-years in the
Number of employees with
≥1 sickness absence due to
CMD=9904
From 2001 to 2007, CMD sickness
absence median time to onset
recurrence (in months) (95% CI):
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Table 3 Continued
Author(s) Country Mental disorders Outcome measure
Number of episodes or
employees
Reported outcomes of sickness
absences
(distress and adjustment
disorders) (ICD-10 R45, F43)
and psychiatric (mild to
moderate depressive and
anxiety disorders) (ICD-10
F32, F40, F41)
subpopulation of men and women
with a previous episode of sickness
absence due to a CMD
Worker-years=years of coverage
from index episode to end of
employment period
Total number of sickness
absences due to
CMD=12 404
Total=10 (10 to 11)
Distress symptoms=11 (10 to 12)
Adjustment disorder=11 (9 to 12)
Depressive symptoms=10 (7 to 12)
Anxiety symptoms=10 (7 to 14)
Other CMD disorders=8 (6 to 9)
Reis et al 11 BR Mental and behavioural
disorders (ICD-10 F00-F99)
Duration of episode=Number of
calendar days absent from work
Recurrence density=number of
recurrent sickness absences
divided by total worker-time at risk
for the subsequent sickness
absences
Number of sickness absence
episodes:
Due to any disorder=5138
Due to mental and
behavioural disorders=324
Recurrence density/100
worker-months:
Due to any disorder =17.37
Due to mental and behavioural
disorders=6.72
Roelen et al 10 NL Mental and behavioural
disorders from medical
certification (ICD-10 F00-F99)
Recurrence density=number of
employees with recurrent episodes
by the worker-years in the
subpopulation of men and women
with a previous episode of sickness
absence
Number of employees with
≥1 sickness absence=36 342
Number of employees with
≥1 sickness absence due to
mental and behavioural
disorders=7197
Number of employees with >1
sickness absence due to
mental and behavioural
disorders=1400
Worker-years=363 461
From 2001 to 2007,
Recurrence density/1000
worker-years (95% CI):
Mental and behavioural
disorders=80.4 (74.9 to 86.0)
Any disorder=81.6 (79.1 to 84.0)
Median days to recurrence (in days)
(95% CI):
Mental and behavioural
disorders=328 (284 to 372)
Any disorder=384 (367 to 401)
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could represent high costs. One estimate suggested that it
could cost $C80 000 per long-term disability claim.5
The results of the studies suggest that sickness absence
duration ranges from 5 to 119 days. The variation
among the estimates may reflect the variation among
the sickness benefit schemes of the jurisdictions in
which the studies were conducted. However, there were
consistencies among a number of reported patterns. For
example, the numbers of sickness absence days related
to mental disorders were greater than those for physical
disorders in the four studies that reported them.6 9 14 15
In addition, compared to absences related to physical
disorders, those related to mental disorders may be of
greater length and in turn, burden.
With regard to sickness absence recurrence, the
studies that calculated sickness absence recurrence rates
reported rates that ranged from 7/100 worker months
to 80/1000 worker-years. While there is variation in the
magnitudes of the reported rates, two studies also indi-
cated that the time between a sickness absence recur-
rence is consistently longer for workers who had a past
sickness absence related to a physical disorder versus a
mental disorder. However, while the pattern seemed to
be consistent, the median numbers of sickness absence
free days were two to three times greater in Dewa
et al’s12 study than Roelen et al’s.10 Owing to the fact that
workers within the respective studies are exposed to the
same sickness benefit scheme, the differences within the
studies suggest there may be other potential contribu-
tors to the differences than solely the sickness benefit
scheme. There is an opportunity for future research to
explore the role that individual (eg, the chronic nature
of mental disorders), occupational (eg, job character-
istics) and environmental (eg, workplace stigma) factors
play in the differences in the recurrence of physical
versus mental disorder-related sickness absences.
These results also suggest that although most workers
RTW, they also may be at risk of a repeat sickness absence
episode. Indeed, the literature suggests that mental disor-
ders such as depression are chronic in nature and have a
high recurrence rate.19–21 However, does symptom
relapse automatically necessitate an accompanying sick-
ness absence? Given that work disability is not solely a
medical problem, there have been suggestions that the
prognosis need not be fatalistic; sickness absence is not
always required. For example, workplace accommoda-
tions could help workers experiencing an episode of
mental illness continue to work during an episode.22 23
In addition, there is an emerging literature looking at the
effectiveness of interventions in decreasing sickness
absence recurrence for mental disorders.24 25 That is,
although there have been arguments for treating mental
disorders as chronic illnesses, there have been few inter-
vention studies that have focused on decreasing sickness
absence recurrence for mental disorders.
This also points to one of the gaps in the literature. Few
studies have estimated the components of the cost of work
reintegration and accommodation for workers with mental
disorders. None of the studies identified in this review
examined the time it took for a worker to completely
reintegrate back into work. For example, how long is the
work accommodation period? Furthermore, how is prod-
uctivity affected during the reintegration period? There is
evidence suggesting that there may be costs to the
employer related to the process of reintegrating a worker
who has been absent because of a sickness episode.22 26 27
There also is evidence to suggest that employers and
workers have identified work sustainability without sickness
absence recurrence as an important work outcome.28
Given that work sustainability without sickness absence
recurrence seems to be a preference of workers and
employees and there are potential costs related to reinte-
gration and accommodation, it may be important to con-
sider the number of episodes (ie, recurrence rates) as well
as total number of absence days alone. Few burden of
illness studies for mental disorders have included the costs
of recurrent sickness absence in their estimates. However,
recurrent sickness absence episodes seem to be a cost that
warrants consideration for inclusion in cost estimates as
well as for intervention outcomes.
In addition, five of the 10 studies identified are from
one country (the Netherlands) and two population
groups within that country. At the same time, the data-
bases that were used represented between 10 000 and
100 000 claims. Thus, the findings that emerge from
these databases build a compelling case that the length
of sickness absence and its recurrence is a burden on
employers. However, the fact that the majority of the evi-
dence is being generated by one country raises interest-
ing questions. Is the reason that the Netherlands and
Northern Europe are the sources of most of the inter-
vention studies for sickness absences related to mental
disorders because they have compelling data to make
the case about the costs to employers? Are the results
from the Netherlands generalisable to other countries?
In addition to the Dutch studies, there were five other
studies identified. However, these studies actually repre-
sented a total of four population groups. Three of the
datasets each represented about 5000 claims from single
organisations (the studies from the UK, Canada and one
Brazilian study). The exception was the one Brazilian
study that represented 140 000 claims (all workers in
registered private sector jobs). This suggests that there is
an opportunity for the evidence base to grow in these
countries. It also begs the question, ‘What is known
about the sickness absence burden in other countries
that were not represented in this search (ie, the USA,
the missing European Union countries and Asia)?’ Does
the absence of studies from other countries indicate that
it is not a concern in the other countries? Or, is it an
indication that awareness is yet to be raised?
Strengths and limitations related to
interpreting the literature
There were a number of strengths of the current body
of literature reviewed. First, all of the data from the
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included studies used data from complete populations
of people who had a sickness absence. This minimises
the potential for selection bias within populations.
However, selection bias related to the population chosen
is still a possibility. Indeed, there was variation in the
populations covered ranging from multiple to single
organisations. Consequently, it will be important for
future work to examine whether the results are general-
isable to different populations.
An additional strength of the included studies was
that they used standardised diagnostic classification
systems. All included depressive and anxiety disorders as
well as stress-related disorders. However, there was vari-
ability in the other types of mental disorders considered.
This could have affected some of the reported results.
At the same time, it should be noted that the majority of
sickness absences related to mental disorders are attrib-
utable to depression, anxiety and stress-related disor-
ders.29 30 This suggests that inclusion of these disorders
would capture a large proportion of the sickness
absences related to mental disorders.
A limitation of the studies was the variation in the
years from which the data were taken. Although all
studies used post-2000, there could have been changes
within systems that could have affected incidence rates.
For example, in the Netherlands, extensive legislative
changes occurred between 2000 and 2013 which
affected rates.7 31 In fact, the changes are reflected in
the results reported by Roelen et al16 Similarly, changes
could have been implemented in other countries such
that results may not currently be generalisable.
Another limitation was variability in the sickness
absence benefit schemes. That is, the variation in the
length of sickness absence episodes in part could be
related to the length of sickness absence coverage. The
longer the coverage, the longer the absence may be.
The frequency of sickness absence recurrence also could
be affected by the benefit scheme. If there are limits on
the number of sickness absence days that a worker is
allowed annually, those workers could have fewer epi-
sodes than workers for whom limits do not exist.
Strengths and limitations of the search strategy
Although five databases were used in the search, articles
that did not appear in any of the databases could have
been overlooked. This possibility was decreased due to
the broad scope of each of the searched databases and
the manual search. Another limitation is related to the
fact that the search focused on articles published in
English-language journals. However, despite the
English-language constraint, the identified studies origi-
nated in European, North American and Latin
American countries. This indicates that although they
are not in countries where English is the first language,
at least some of these researchers publish in
English-language journals.
It should be noted that the sickness absence outcomes
that have been studied are related to the potential direct
costs to employers. That is, because of the effect on
work productivity, employers will be interested in the
length of sickness absences as well as recurrence of sick-
ness absence. However, from a societal perspective, this
presents only part of picture. What happens to workers
who do not RTW? This is a question governments may
want answered especially if it means that those workers
become enrolled in the public disability programmes.32
Thus, future work should also examine this group of
workers particularly if factors can be identified that
retain them in the labour market.
CONCLUSIONS
This systematic literature review identified only 10
studies published in the last decade. The results of these
existing studies suggest that along with the incidence of
sickness absence related to mental disorders, the length
and recurrence (ie, frequency of recurrence and time
between recurrence) of these sickness absences should
be areas of concern.
This systematic review also highlights gaps in the litera-
ture. For instance, half of the existing studies are from the
Netherlands. That is, most of the literature in this area is
based on the Netherland’s experience. This suggests that
in other parts of the world, this area of research is in its
infancy. It will be important for research in other countries
to look at the length and sickness absence recurrence (ie,
frequency of recurrence and time between recurrences)
of sickness absences. This basic knowledge will help with
understanding to what extent it should be a concern for
employers in other countries. In turn, it could also help to
build the business case for increased resources towards the
development of more sickness absence interventions in
these other countries.
The results of this review also indicate that we are in
the early stages of understanding the aspects of sickness
absences that contribute to employer burden and along
the same vein, areas to target to effectively decrease
costs. For example, more research is needed regarding
the costs of recurrence including the cost of reintegra-
tion and time to full reintegration. This suggests that
current cost estimates may underestimate the costs of
sickness absences from the employer’s perspective. To
effectively build the business case for employers to invest
in interventions that target sickness absences related to
mental disorders, it will be important to develop a more
comprehensive picture of the costs associated with sick-
ness absence that employers directly bear. Only in this
way can economic evaluations and economic models
accurately estimate the types of cost savings that employ-
ers can expect with an intervention.
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